J. Safra Sarasin Holding AG Sells 4,316 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Key Points

• J. Safra Sarasin Holding AG reduced its stake in Henry Schein, Inc. by 19.5%, leaving it with 17,782 shares valued at approximately $1.22 million.
• Analysts have lowered price targets for Henry Schein, with Wells Fargo reducing its target from $80.00 to $75.00, while overall ratings remain mixed, with nine "hold" and four "buy" ratings.
• Henry Schein's latest earnings report showed an EPS of $1.15, exceeding estimates, but revenue of $3.17 billion fell short of forecasts and reflected a year-over-year decline of 0.1%.

J. Safra Sarasin Holding AG lowered its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 19.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 17,782 shares of the company's stock after selling 4,316 shares during the period. J. Safra Sarasin Holding AG's holdings in Henry Schein were worth $1,218,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in HSIC. Invesco Ltd. grew its holdings in Henry Schein by 0.4% during the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock worth $343,468,000 after acquiring an additional 17,552 shares in the last quarter. FMR LLC increased its stake in Henry Schein by 6.6% during the 4th quarter. FMR LLC now owns 3,498,033 shares of the company's stock valued at $242,064,000 after buying an additional 217,143 shares during the period. Geode Capital Management LLC increased its stake in Henry Schein by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock valued at $218,762,000 after buying an additional 14,876 shares during the period. Palestra Capital Management LLC acquired a new position in Henry Schein during the 4th quarter valued at about $182,988,000. Finally, Fiduciary Management Inc. WI increased its stake in Henry Schein by 7.2% during the 4th quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company's stock valued at $172,193,000 after buying an additional 167,990 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Analyst Ratings Changes

HSIC has been the topic of several recent research reports. Piper Sandler lowered their price objective on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 30th. Barrington Research dropped their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 6th. Wall Street Zen downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Robert W. Baird reissued a "neutral" rating and issued a $72.00 target price (down from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Finally, Wells Fargo & Company decreased their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Nine equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, Henry Schein has an average rating of "Hold" and an average price target of $78.08.

Henry Schein Price Performance

Shares of HSIC stock traded down $5.19 during mid-day trading on Tuesday, reaching $64.83. The company's stock had a trading volume of 4,502,243 shares, compared to its average volume of 1,791,472. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The company has a market cap of $7.89 billion, a P/E ratio of 20.26, a PEG ratio of 2.26 and a beta of 0.81. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.75 and a current ratio of 1.38. The firm's 50-day moving average is $71.41 and its two-hundred day moving average is $71.26.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). The business had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The firm's revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period last year, the business posted $1.23 EPS. On average, research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.